CA Patent

CA3142081A1 — Lipid-controlled release compositions

Assigned to Camurus AB · Expires 2020-12-03 · 5y expired

What this patent protects

The disclosure provides a glass syringe or a glass cartridge, containing a lipid-based pre-formulation suitable for refrigerated storage.

USPTO Abstract

The disclosure provides a glass syringe or a glass cartridge, containing a lipid-based pre-formulation suitable for refrigerated storage.

Drugs covered by this patent

Patent Metadata

Patent number
CA3142081A1
Jurisdiction
CA
Classification
—
Expires
2020-12-03
Drug substance claim
No
Drug product claim
No
Assignee
Camurus AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.